Tacrolimus in refractory polymyositis with interstitial lung disease

Lancet

Volumn 353, Issue 9166, 1999, Pages 1762-1763

  Oddis, Chester V ^a   Sciurba, Frank C ^a   Elmagd, Kareem Abu ^a   Starzl, Thomas E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBON MONOXIDE; CREATINE KINASE; OXYGEN; PREDNISONE; SYNTHETASE; TACROLIMUS;

ADULT; AGED; ANEMIA; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DISABILITY; DRUG TOLERABILITY; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; GYNECOMASTIA; HAND DISEASE; HUMAN; HYPERTENSION; INFLAMMATORY DISEASE; INTERSTITIAL LUNG DISEASE; KIDNEY DISEASE; LUNG FUNCTION TEST; LUNG PARENCHYMA; MALE; MUSCLE STRENGTH; MYOSITIS; ORAL DRUG ADMINISTRATION; POLYARTHRITIS; POLYMYOSITIS; PRIORITY JOURNAL; RADIODIAGNOSIS; T LYMPHOCYTE ACTIVATION; TOTAL LUNG CAPACITY;

EID: 0033594767     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)01927-3     Document Type: Article

References (5)

1. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific antibodies define useful homogeneous patient groups. Medicine 1991; 70: 360-74.
2. Jaffe MM, Love LA, Leff RL, et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 1993; 94: 379-87.
3. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in PM and DM. Semin Arthritis Rheum 1988; 18: 29-37.
4. Thomson AW, Carroll PB, McCauley J, et al. FK 506: A novel immunosuppressant for treatment of autoimmune disease. Springer Semin Immunopathol 1992; 14: 323-44.
5. Yocum DE. Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheumatic Dis Clin N Am 1996; 22: 133-53.